Study Activation: Top Four Takeaways from Research Sites
While enrolling subjects is arguably the most crucial aspect of clinical research operations, this cannot be done without activating a
Reviews
Understanding the Current and Future States of Cell and Gene Therapy Research
Explore the current and future landscape of gene therapy research, from advancements in oncology to strategies for improving review efficiency.
Cell & Gene Therapy vs Drug Research: What’s the Difference?
Cell and gene therapy’s popularity has grown exponentially in the past year. However, it’s important to understand how cell and gene therapy research is different from traditional drug development.
IBC Overview eLearning Module
Learn the essentials of institutional biosafety committees (IBCs), their role in research, and how they differ from IRBs in this eLearning module.
Q&A from Remote Monitoring: Study Compliance In A Changing World
In a recent webinar, Advarra experts Emily Eldh and Ben Shankle provided insights and information in Remote Monitoring: Study Compliance
Improving Access to Research for Diverse and Underserved Populations
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
Discover how IQVIA and Advarra accelerated COVID-19 vaccine trials with IBC approvals in under two days, activating sites 71% faster.
What Is an Institutional Biosafety Committee?
An Institutional Biosafety Committee (IBC) evaluates risks in gene therapy research to ensure safety and compliance with NIH guidelines. Learn when IBC review is needed.
Q&A: FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
Phase I Oncology Clinical Trials
In a recent blog, we described the complexity and uniqueness of Phase I clinical trials, outlining the fact that some
Study Startup Success for BioPharma and MedTech: Engage a Research Compliance Partner
A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts
The State of Clinical Trial Activation at Sites Report
Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.